JP2023549098A5 - - Google Patents
Info
- Publication number
- JP2023549098A5 JP2023549098A5 JP2023526375A JP2023526375A JP2023549098A5 JP 2023549098 A5 JP2023549098 A5 JP 2023549098A5 JP 2023526375 A JP2023526375 A JP 2023526375A JP 2023526375 A JP2023526375 A JP 2023526375A JP 2023549098 A5 JP2023549098 A5 JP 2023549098A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- receptor
- cells
- car
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026079789A JP2026121415A (ja) | 2020-11-04 | 2026-05-11 | 固形腫瘍を標的とする多重操作されたiPSC及び免疫エフェクター細胞 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063109842P | 2020-11-04 | 2020-11-04 | |
| US63/109,842 | 2020-11-04 | ||
| US202163228490P | 2021-08-02 | 2021-08-02 | |
| US63/228,490 | 2021-08-02 | ||
| PCT/US2021/072255 WO2022099297A1 (en) | 2020-11-04 | 2021-11-04 | Multiplexed engineered ipsc and immune effector cells targeting solid tumors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026079789A Division JP2026121415A (ja) | 2020-11-04 | 2026-05-11 | 固形腫瘍を標的とする多重操作されたiPSC及び免疫エフェクター細胞 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023549098A JP2023549098A (ja) | 2023-11-22 |
| JP2023549098A5 true JP2023549098A5 (cg-RX-API-DMAC7.html) | 2024-11-13 |
| JP7863553B2 JP7863553B2 (ja) | 2026-05-21 |
Family
ID=81456848
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023526375A Active JP7863553B2 (ja) | 2020-11-04 | 2021-11-04 | 固形腫瘍を標的とする多重操作されたiPSC及び免疫エフェクター細胞 |
| JP2026079789A Pending JP2026121415A (ja) | 2020-11-04 | 2026-05-11 | 固形腫瘍を標的とする多重操作されたiPSC及び免疫エフェクター細胞 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026079789A Pending JP2026121415A (ja) | 2020-11-04 | 2026-05-11 | 固形腫瘍を標的とする多重操作されたiPSC及び免疫エフェクター細胞 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230381235A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4240834A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7863553B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230096110A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021376382A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3196555A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL302481A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023004326A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022099297A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL303269A (en) | 2020-12-03 | 2023-07-01 | Century Therapeutics Inc | Genetically engineered cells and uses thereof |
| US11661459B2 (en) | 2020-12-03 | 2023-05-30 | Century Therapeutics, Inc. | Artificial cell death polypeptide for chimeric antigen receptor and uses thereof |
| TW202241935A (zh) | 2020-12-18 | 2022-11-01 | 美商世紀治療股份有限公司 | 具有可調適受體專一性之嵌合抗原受體系統 |
| US20230288405A1 (en) * | 2022-01-20 | 2023-09-14 | 3T Biosciences, Inc. | T cell receptor (tcr) compositions and methods for optimizing antigen reactive t-cells |
| JP2025520225A (ja) * | 2022-05-18 | 2025-07-02 | シアトル チルドレンズ ホスピタル ディー/ビー/エイ シアトル チルドレンズ リサーチ インスティテュート | 多重特異性結合剤の製造および/または送達 |
| GB202208545D0 (en) * | 2022-06-10 | 2022-07-27 | Adaptimmune Ltd | Production of immune cells |
| EP4780945A1 (en) * | 2023-09-20 | 2026-07-29 | Kure.AI, Inc. | Methods and reagents to improve cell therapy with the creation of novel car-targeting mr1 protein |
| WO2025067318A1 (zh) * | 2023-09-28 | 2025-04-03 | 沛尔生技医药股份有限公司 | 具有细胞内信号传导结构域及自然杀伤蛋白30跨膜结构域的核酸分子及包含其的嵌合抗原受体 |
| GB202318950D0 (en) * | 2023-12-12 | 2024-01-24 | Adaptimmune Ltd | Production of immune cells |
| WO2026019829A1 (en) * | 2024-07-15 | 2026-01-22 | A2 Biotherapeutics, Inc. | Compositions and methods for stimulating t cells used in cell therapy with a bispecific bridging molecule |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108456247A (zh) * | 2017-02-20 | 2018-08-28 | 上海恒润达生生物科技有限公司 | 靶向ny-eso-1的t细胞受体及其用途 |
| GB201717578D0 (en) | 2017-10-26 | 2017-12-13 | Univ College Cardiff Consultants Ltd | Novel T-cell receptor |
| CA3090793C (en) * | 2018-02-16 | 2024-10-08 | Kite Pharma, Inc. | MODIFIED MULTIPOTENTED STEM CELLS, AND METHODS OF PREPARATION AND USE |
| KR102892744B1 (ko) * | 2018-04-19 | 2025-11-28 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | Mage-b2 특이성을 갖는 t 세포 수용체 및 이의 용도 |
| EP3632460A1 (en) * | 2018-10-05 | 2020-04-08 | St. Anna Kinderkrebsforschung | A group of chimeric antigen receptors (cars) |
| CN113906133A (zh) | 2019-04-11 | 2022-01-07 | 菲特治疗公司 | 工程改造的iPSC和免疫效应细胞中的CD3重建 |
| US20220213198A1 (en) * | 2019-05-22 | 2022-07-07 | The Council Of The Queensland Institute Of Medical Research | Method of treatment |
-
2021
- 2021-11-04 WO PCT/US2021/072255 patent/WO2022099297A1/en not_active Ceased
- 2021-11-04 JP JP2023526375A patent/JP7863553B2/ja active Active
- 2021-11-04 CA CA3196555A patent/CA3196555A1/en active Pending
- 2021-11-04 IL IL302481A patent/IL302481A/en unknown
- 2021-11-04 EP EP21890337.5A patent/EP4240834A4/en active Pending
- 2021-11-04 AU AU2021376382A patent/AU2021376382A1/en active Pending
- 2021-11-04 MX MX2023004326A patent/MX2023004326A/es unknown
- 2021-11-04 US US18/250,737 patent/US20230381235A1/en active Pending
- 2021-11-04 KR KR1020237018628A patent/KR20230096110A/ko active Pending
-
2026
- 2026-05-11 JP JP2026079789A patent/JP2026121415A/ja active Pending